MOHAWK INDUSTRIES INC
MHKAbout the company
Mohawk Industries, Inc. designs, manufactures, sources, distributes, and markets flooring products for residential and commercial remodeling, and new construction channels in the United States, Europe, Latin America, and internationally. It operates through three segments: Global Ceramic, Flooring North America, and Flooring Rest of the World.
Investment snapshot
Positive
5
BUY / PASS
Neutral / negative
5 / 6
NEUTRAL / FAIL
Median fair value
$104.82
-28.9% vs price
Models with upside
1 / 17
Positive margin of safety
Strongest signal
10 of 12 pass — Lynch and Asness object
Key risk
Models split on MHK at $147.38 — fair values range $34.85–$151.94
Framework analysis
| Verdict | Meaning |
|---|---|
| BUY | Positive purchase signal: the framework's buy requirements are met. |
| PASS | The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state. |
| NEUTRAL | Neither a positive nor negative conclusion. It does not mean to hold an existing position. |
| FAIL | The company does not clear the framework's requirements. |
| Ranked | Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL. |
Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.
| Metric | Graham Defensive Value | Buffett Quality Compounder | Lynch GARP | Greenblatt Magic Formula | Piotroski F-Score | Dreman Contrarian Value | Munger Quality Focus | Pabrai Dhandho Framework | Akre Three-Legged Stool | Marks Risk-Aware Value | Ackman Activist Value | Templeton Global Bargain Hunter | Sleep Scale Economies Shared | Asness Systematic Factors | Neff Low-P/E Total Return | Schloss Asset-Value Discipline | O'Shaughnessy Systematic Factor Composite |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verdict | FAIL | FAIL | FAIL | FAIL · Rank #1285 (Top 41.5%) | NEUTRAL | PASS | NEUTRAL | FAIL | FAIL | NEUTRAL | PASS | PASS | PASS | BUY | FAIL | NEUTRAL | NEUTRAL |
| Score | |||||||||||||||||
| Analysis | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… |
| Intrinsic Value (annual) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||||||||
| Margin of Safety | -9.3% | -31.6% | N/A | -286.0% | N/A | -322.9% | -13.8% | -121.8% | +3.0% | -28.0% | -50.9% | -120.3% | N/A | N/A | N/A | N/A | N/A |
| Financial Basis | TTM ended 2026-10-03 · Balance sheet at 2026-10-03 · Annual history · FY 2025 Latest source filing: 2026-10-30 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-10-03 Latest source filing: 2026-10-30 Score computed: 2026-11-14 | Annual history · FY 2025 · Balance sheet at 2026-10-03 · TTM ended 2026-10-03 vs 2025-09-27 · TTM ended 2026-10-03 Latest source filing: 2026-10-30 Score computed: 2026-11-14 | TTM ended 2026-10-03 Latest source filing: 2026-10-30 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-02-24 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-10-03 · Balance sheet at 2026-10-03 · Market data at 2026-11-01 Latest source filing: 2026-10-30 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2025 · TTM ended 2026-10-03 · Balance sheet at 2026-10-03 Latest source filing: 2026-10-30 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2025 Latest source filing: 2026-02-24 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment · TTM ended 2026-10-03 · Balance sheet at 2026-10-03 Latest source filing: 2026-10-30 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-10-03 · Qualitative assessment Latest source filing: 2026-10-30 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-10-03 · Balance sheet at 2026-10-03 · Market data at 2026-11-01 Latest source filing: 2026-10-30 Score computed: 2026-11-14 | Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 · Balance sheet at 2026-10-03 Latest source filing: 2026-10-30 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-02-24 Score computed: 2026-11-14 | TTM ended 2026-10-03 · Balance sheet at 2026-10-03 · Price history 2025-01-01–2026-11-01 · Annual history · FY 2025 Latest source filing: 2026-10-30 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-10-03 Latest source filing: 2026-10-30 Score computed: 2026-11-14 | Annual history · FY 2025 · Balance sheet at 2026-10-03 Latest source filing: 2026-10-30 Score computed: 2026-11-14 | TTM ended 2026-10-03 · Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 Latest source filing: 2026-10-30 Score computed: 2026-11-14 |
Where It Passes
- Debt & Leverage83% pass✓ 13✗ 2▾
10 of 12 pass — Lynch and Asness object
LT Debt vs Net Current AssetsLT Debt $1.2B vs NCA $2.9B✓GrahamLT Debt <= Net Current AssetsDebt/Equity & Interest CoverageD/E: 0.21, IC: 62.1x✓BuffettD/E < 0.5 AND Interest Coverage > 5xTotal Debt / Equity0.21✓Lynch< 0.33Cash - Long-term Debt$-344.0M✗LynchPositive preferredLT Debt / Total Assets Change13.17% -> 12.72%✓PiotroskiDecreased YoYCurrent Assets / Current Liabilities1.91✓Dreman> 1.5✓SchlossCurrent ratio >= 1.50x (app cutoff)Total Debt / Shareholders' Equity0.21✓Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00xDebt Levels0.21✓MungerDebt/Equity < 0.5✓AkreDebt/Equity < 0.3Interest Coverage & Debt/EBITDAIC=62.1x, D/EBITDA=1.4x✓MarksInterest Coverage > 3x; Debt/EBITDA < 4xTotal Debt / Shareholders Equity0.21✓Ackman<= 1.0Negative debt-to-equity (higher means less debt)-0.2147; #1729/4210 (top 41.1%)✗AsnessTop 30% of eligible cross-section - Cash Flow70% pass✓ 9✗ 3▾
7 of 10 pass — Dreman, Pabrai and Oshaughnessy object
Free Cash Flow Proxy$582.5M✓BuffettPositive and growingFCF Positive and Growing$891.5M✓LynchPositive and growingOperating Cash Flow$1.1B✓PiotroskiCFO > 0(CFO / Total Assets) vs ROACFO/Assets=7.72%, ROA=2.70%✓PiotroskiCFO/Assets > ROAPrice / (CFO / Shares)8.6x✗Dreman< 8xP/E or FCF YieldP/E=24.9x, FCF Yield=7.2%✗PabraiP/E < 15 or FCF Yield > 10%FCF Positive18/18 years FCF positive✓MarksPositive FCF in majority of recent years(OCF - CapEx) / Market Cap9.8%✓Ackman>= 4%Price / FCF per Share14.7x✓Ackman<= 25Positive Operating Cash Flow frequency18/18 years positive✓SleepPositive OCF in >= 70% of available yearsOperating Cash Flow - Capital Expenditures$891.5M✓Neff> $0 (app proxy for a strong fundamental case)(Operating cash flow - capex) / market capitalization+10.41%; #710/4519 (top 15.7%)✗OshaughnessyTop 10% of eligible cross-section
Where It Falls Short
- Valuation models10% pass✓ 1✗ 9▾
Models split on MHK at $147.38 — fair values range $34.85–$151.94
Graham fair value$134.80✗Graham-9.3% margin vs $147.38Buffett fair value$111.97✗Buffett-31.6% margin vs $147.38Greenblatt fair value$38.18✗Greenblatt-286.0% margin vs $147.38Dreman fair value$34.85✗Dreman-322.9% margin vs $147.38Munger fair value$129.56✗Munger-13.8% margin vs $147.38Pabrai fair value$66.46✗Pabrai-121.8% margin vs $147.38Akre fair value$151.94✓Akre+3.0% margin vs $147.38Marks fair value$115.12✗Marks-28.0% margin vs $147.38Ackman fair value$97.67✗Ackman-50.9% margin vs $147.38Templeton fair value$66.90✗Templeton-120.3% margin vs $147.38 - Profitability13% pass✓ 8✗ 27▾
14 of 16 flag MHK's profitability — Graham, Buffett, Lynch +11 more
Net income / market capitalization+6.05%; #1405/6340 (top 22.2%)✓AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionPositive EPS (10 years)15/18 years positive✗GrahamPositive EPS every year for 10 yearsEPS Growth (3-yr avg, 10-yr window)N/A (negative base EPS)✗Graham>= 33% growthNet Income Positive (10+ years)15/18 years positive✗BuffettPositive every year for 10+ yearsROE (up to 5-year arithmetic mean)3.6%✗Buffett> 15% arithmetic mean (app rule)Operating Margin (10-yr trend)4.5% (latest)✗BuffettStable or rising over 10 yearsFree Cash Flow Proxy$582.5M✓BuffettPositive and growingEarnings Variance (10-yr CoV)1.74✗BuffettCoV < 0.3Retained Earnings Effectiveness✗Buffett$1 retained -> > $1 market value createdBasic earnings-growth PEG (dividends excluded)P/E 24.9x (growth N/A)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR-3.9%✗Lynch15-30% (Fast Grower); > 0% to passROE6.2%✗Lynch> 15%EBIT / Enterprise Value6.5%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=6.5%, ROC=8.6%✗GreenblattBoth EY > 10% and ROC > 25%Net Income / Total Assets2.70%✓PiotroskiROA > 0ROA Change YoY4.04% -> 2.70% (delta: -1.34%)✗PiotroskiCurrent ROA > Prior ROA(CFO / Total Assets) vs ROACFO/Assets=7.72%, ROA=2.70%✓PiotroskiCFO/Assets > ROAGross Margin Change YoY24.8% -> 23.9%✗PiotroskiImproved YoYPre-Tax Income / Revenue5.4%✗Dreman>= 8%Net Income / Shareholders' Equity6.2%✗Dreman> 12%Margin of SafetyP/E=24.9x, P/B=1.1x✓PabraiP/B < 1.5 or P/E < 15Return on Equity1.8% (3-yr avg)✗AkreROE > 20% (3-year avg)Discount to Intrinsic Value-311.1% (IV=$35.85 vs Price=$147.38)✗Marks>= 20% below intrinsic valuePositive Net Income Frequency15/18 years positive✓MarksPositive net income in >= 7 of last 10 yearsOperating Income / Revenue5.5%✗Ackman>= 15%Net Income / Shareholders Equity6.2%✗Ackman>= 15%5-Year EPS CAGR-3.9% CAGR over 5 years✗Templeton> 0% (5-year EPS CAGR)Operating Margin Trend-2.6% (2023) -> 4.5% (2025)✓TempletonNon-negative operating-margin trend over 3 yearsRevenue growth vs. gross and operating margin trendgross margin 24.3% -> 23.9%, operating margin -2.6% -> 4.5%✗SleepRevenue rising; gross margin flat or falling; operating margin holdingGross profit / total assets+20.61%; #2027/3702 (top 54.8%)✗AsnessTop 30% of eligible cross-sectionNet income / positive book equity+6.24%; #2307/5226 (top 44.1%)✗AsnessTop 30% of eligible cross-sectionNegative 5-year standard deviation of ROA-0.0357; #2131/5884 (top 36.2%)✗AsnessTop 30% of eligible cross-section3-5 Year Diluted EPS CAGR-3.9% over 5 years✗Neff7%-20% annualizedPositive Diluted-EPS Years9/10 years positive✓Schloss>= 70% positive over 5-10 observed years (app rule) - Efficiency13% pass✓ 2✗ 9▾
7 of 8 flag MHK's efficiency — Graham, Buffett, Greenblatt +4 more
Current Ratio1.91✗Graham>= 2.0ROIC (3-5 yr avg)3.9%✗Buffett> 10%ROIC - WACC-6.1%✗BuffettPositive (WACC = 10%)EBIT / (NWC + Net Fixed Assets)8.6%✗Greenblatt> 25%Current Ratio Change YoY2.04 -> 2.19✓PiotroskiIncreased YoYRevenue / Total Assets Change YoY0.85x -> 0.79x✗PiotroskiImproved YoYCurrent Assets / Current Liabilities1.91✓Dreman> 1.5Return on Invested Capital4.9%✗Munger> 15%ROIC (high and growing)FY2023: ROIC=-2.2%; FY2024: ROIC=5.6%; FY2025: ROIC=3.7%✗AkreLatest 3 consecutive FYs: ROIC > 15% in eachReinvestment Rate x ROIC3.7% (RR=100% x ROIC=3.7%)✗AkreReinvestment Rate * ROIC > 10%ROIC (5-year)0/5 years above 12% (latest 3.7%)✗SleepROIC > 12% in a majority of years - Valuation23% pass✓ 9✗ 19▾
10 of 13 flag MHK's valuation — Graham, Lynch, Greenblatt +7 more
Price / Book Value per Share1.1x✓Dreman< 1.2x✓Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)Net income / market capitalization+6.05%; #1405/6340 (top 22.2%)✓AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionPrice / 3-yr avg EPS61.7x✗Graham<= 15xPrice-to-Book Ratio1.1x✓Graham<= 1.5xP/E x P/B66.70✗Graham<= 22.5Basic earnings-growth PEG (dividends excluded)P/E 24.9x (growth N/A)✗Lynch< 1.0 (ideally < 0.5)EBIT / Enterprise Value6.5%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=6.5%, ROC=8.6%✗GreenblattBoth EY > 10% and ROC > 25%Price / EPS24.9x✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)Price / (CFO / Shares)8.6x✗Dreman< 8xValuation ReasonablenessP/E=24.9x, OE Yield=6.4%✓MungerP/E < 25 or Owner Earnings Yield > 5%P/E or FCF YieldP/E=24.9x, FCF Yield=7.2%✗PabraiP/E < 15 or FCF Yield > 10%P/B or P/E vs. Historical AverageP/E=24.9x, P/B=1.1x✓MarksP/E < 15 or P/B < 2.0Discount to Intrinsic Value-311.1% (IV=$35.85 vs Price=$147.38)✗Marks>= 20% below intrinsic valuePrice / FCF per Share14.7x✓Ackman<= 25Price vs. Trailing Low150% of trailing low ($98.46)✗Templeton<= 120% of trailing low (certified split-adjusted live window)Positive book equity / market capitalization+0.9690; #1542/6449 (top 23.9%)✓AsnessTop 30% of eligible cross-sectionPrice / Diluted EPS24.9x✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)(EPS CAGR % + Dividend Yield %) / P/E✗Neff> 0.7 (Neff's published traditional edge)Price / Tangible Book Value per Share1.29x✗SchlossP/TBV <= 1.00x (app cutoff)Book Value per Share Change+12.1%✓SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)Revenue / market capitalization+1.3079; #1490/5247 (top 28.4%)✗OshaughnessyTop 10% of eligible cross-section(Operating cash flow - capex) / market capitalization+10.41%; #710/4519 (top 15.7%)✗OshaughnessyTop 10% of eligible cross-sectionTrailing six-month price return through the evaluation date+39.62%; #821/6202 (top 13.2%)✗OshaughnessyTop 10% of eligible cross-section - Growth25% pass✓ 4✗ 9▾
6 of 8 flag MHK's growth — Graham, Lynch, Ackman +3 more
EPS Growth (3-yr avg, 10-yr window)N/A (negative base EPS)✗Graham>= 33% growthBasic earnings-growth PEG (dividends excluded)P/E 24.9x (growth N/A)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR-3.9%✗Lynch15-30% (Fast Grower); > 0% to passInventory Growth vs Revenue GrowthInv: -3.8% vs Rev: 4.5%✓LynchInventory growth < Revenue growthEPS Growth Direction$-21.32 (2008) -> $5.93 (2025)✓DremanPositive over recent yearsEPS CAGR5.5% CAGR over 15 years✓Dreman> 5% annualizedPositive Net Income Frequency15/18 years positive✓MarksPositive net income in >= 7 of last 10 years3yr Median Revenue Growth-2.7%✗Ackman>= 5%Positive EPS Growth Frequency2/5 years with positive EPS growth✗AckmanPositive EPS growth in >= 3 of last 5 years5-Year EPS CAGR-3.9% CAGR over 5 years✗Templeton> 0% (5-year EPS CAGR)Revenue growth vs. gross and operating margin trendgross margin 24.3% -> 23.9%, operating margin -2.6% -> 4.5%✗SleepRevenue rising; gross margin flat or falling; operating margin holding5-year Revenue CAGR2.5%✗SleepCAGR > 7%3-5 Year Diluted EPS CAGR-3.9% over 5 years✗Neff7%-20% annualized - Verdicts42% pass✓ 5✗ 7▾
Split decision: 6 FAIL · 5 NEUTRAL · 4 PASS · 1 BUY
Overall verdict✗GrahamFAIL (3/9)✗BuffettFAIL (2/9)✗LynchFAIL (3/7)✗GreenblattRank #1285•PiotroskiNEUTRAL (F-Score 6)✓DremanPASS (6/11)•MungerNEUTRAL (3/4)✗PabraiFAIL (1/3)✗AkreFAIL (2/6)•MarksNEUTRAL (4/5)✓AckmanPASS (5/9)✓TempletonPASS (4/8)✓SleepPASS (3/6)✓AsnessBUY (Rank #300/2370 (Top 12.7%))✗NeffFAIL (2/6)•SchlossNEUTRAL (4/7)•OshaughnessyNEUTRAL (Not ranked)
Business & financials
Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.
Company Profile
Financial Snapshot
Shareholder Return
Fiscal 2025
Retired 1.8% of shares last year, 3.5% over two.
- Buybacks
- $149.8M
- Dividends
- —
What drove EPS
A buyback raises earnings per share without the company earning more. This splits each year's change into the two.
The two parts do not sum exactly to the total — the difference is the cross-term, plus preferred capital where the company has any. It is left visible rather than distributed into the other two.
Share count is the denominator the filer used for diluted EPS, recovered as net income ÷ EPS — not the balance-sheet count, which is a point-in-time figure and would put the timing difference into this split. Years with a loss are omitted: a smaller share count makes a loss per share larger, so the decomposition inverts.
Company Financials
Latest TTM and quarters alongside annual years
TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.
The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.
| Metric | TTM · 2026-10-03 2025-09-28 – 2026-10-03 Sources · derived quarter valuesDerived from cumulative filings: revenue, net income, operating income, gross profit, ebit, pre tax income, interest expense, operating cash flow, depreciation amortization, capex, buybacks. | Q3 FY 2026 2026-07-05 – 2026-10-03 Sources · derived quarter valuesDerived from cumulative filings: operating cash flow, capex, buybacks. | Q2 FY 2026 2026-04-05 – 2026-07-04 Sources · derived quarter valuesDerived from cumulative filings: operating cash flow, capex, buybacks. | Q1 FY 2026 2026-01-01 – 2026-04-04 Sources | FY 2025Sources
| FY 2024Sources
| FY 2023Sources
| FY 2022Sources
| FY 2021Sources
|
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $8.6Bcurrent | -- | -- | -- | $7.3Best. | $7.7Best. | $6.6Best. | $7.6Best. | $10.3Best. |
| Revenue | $11.2B↑5% | $2.8B↑1% | $3.0B↑7% | $2.7B↑8% | $10.8B | $10.8B↓3% | $11.1B↓5% | $11.7B↑5% | $11.2B |
| Operating Income | $621.5M↑14% | $187.7M↑37% | $253.7M↑34% | $111.8M↑16% | $489.8M↓29% | $693.5M↑338% | -$291.9M↓220% | $244.2M↓82% | $1.3B |
| Net Income | $518.3M↑23% | $163.1M↑50% | $196.1M↑34% | $117.1M↑61% | $369.9M↓28% | $514.7M↑215% | -$449.0M↓1882% | $25.2M↓98% | $1.0B |
| EPS (Diluted) | -- | $2.72↑55% | $3.22↑38% | $1.90↑65% | $5.93↓27% | $8.14↑218% | $-6.90↓1869% | $0.39↓97% | $14.94 |
| Gross Margin | 24.7%↑3% | 25.5%↑7% | 26.6%↑4% | 23.5%↑2% | 23.9%↓4% | 24.8%↑2% | 24.3%↓3% | 25.1%↓14% | 29.2% |
| Operating Margin | 5.5%↑9% | 6.7%↑36% | 8.5%↑26% | 4.1%↑8% | 4.5%↓29% | 6.4%↑344% | -2.6%↓226% | 2.1%↓83% | 11.9% |
| ROE | 6.2%↑24% | — | — | — | 4.4%↓36% | 6.9%↑216% | -5.9%↓1973% | 0.3%↓97% | 12.3% |
| Total Debt | $1.8B↓7% | $1.8B↓7% | $1.9B↓13% | $2.1B↓12% | $2.0B↓9% | $2.2B↓17% | $2.7B↓4% | $2.8B↑21% | $2.3B |
| Shareholders' Equity | $8.3B | $8.3B | $8.5B↑3% | $8.4B↑7% | $8.4B↑12% | $7.5B↓1% | $7.6B↓5% | $8.0B↓5% | $8.4B |
| Current Ratio | 1.91↓15% | 1.91↓15% | 1.92↓10% | 2.16↑7% | 2.19↑7% | 2.04↑15% | 1.78↓7% | 1.92↑8% | 1.78 |
| Debt / Equity | 0.21↓7% | 0.21↓7% | 0.22↓15% | 0.25↓17% | 0.24↓19% | 0.30↓16% | 0.35↑1% | 0.35↑27% | 0.28 |
| Operating Cash Flow | $1.4B↑37% | $471.2M↑22% | $316.5M↑53% | $110.1M↑2876% | $1.1B↓7% | $1.1B↓15% | $1.3B↑99% | $669.2M↓49% | $1.3B |
| Free Cash Flow | $891.5M↑52% | $390.3M↑26% | $228.2M↑81% | $7.8M↑109% | $616.2M↓9% | $679.5M↓5% | $716.3M↑709% | $88.5M↓86% | $633.0M |
Score history
Historical Score Timeline
Industry peers
Industry Peers
Similar companies in Textiles
MHK vs Peers — Financial Grading
| Company | Market Cap | Price | Revenue | Net Income | ROE | D/E | Op. Margin | Curr. Ratio | Graham | Buffett | Lynch | Greenblatt | Piotroski | Dreman |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALBANY INTERNATIONAL CORP /DE/AIN | $1.9B | $68.31 | $1.2B | $57.3M | -7.9% | 0.63 | -3.1% | 2.10 | 4/9 | 1/9 | 1/7 | 0/3 | F-Score 3 | 4/11 |
| INTERFACE INCTILE | $1.8B | $31.00 | $1.4B | $116.1M | 18.1% | 0.28 | 11.8% | 2.34 | 4/9 | 4/9 | 5/7 | 3/3 | F-Score 8 | 7/11 |
| UNIFI INCUFI | $123.1M | $6.62 | $571.3M | $20.3M | -8.2% | — | -1.7% | 3.32 | 3/9 | 0/9 | 2/7 | 0/3 | F-Score 2 | 3/11 |
| CULP INCCULP | $44.1M | $3.46 | $203.5M | $10.2M | -21.2% | 0.40 | -3.5% | 1.79 | 2/9 | 0/9 | 2/7 | 0/3 | F-Score 6 | 3/11 |
| CROWN CRAFTS INCCRWS | $27.1M | $2.52 | $82.3M | $1.8M | 4.7% | 0.36 | 1.3% | 3.58 | 4/9 | 1/9 | 3/7 | 1/3 | F-Score 8 | 7/11 |
| DIXIE GROUP INCDXYN | $9.7M | $0.63 | $257.4M | $7.6M | -86.6% | 9.29 | 0.0% | 0.97 | 2/9 | 0/9 | 1/7 | 0/3 | F-Score 6 | 2/11 |